Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

L-3 Communications enters into agreement to acquire Insight Technology

L-3 Communications announced today that it has entered into an agreement to acquire Insight Technology Incorporated. Insight develops and manufactures mission critical night vision and electro-optical equipment including laser aiming and illumination devices, laser rangefinders, laser markers and designators, night vision goggles and monoculars, and thermal imaging systems.

19 Feb 2010

Passage of DSSA will restrict Americans’ access to nutritional supplements, says Hotze Enterprises

On Feb. 4, Senators John McCain and Byron Dorgan introduced the Dietary Supplement Safety Act of 2010 (DSSA), that if passed, will restrict Americans’ access to nutritional supplements. Hotze Enterprises, a world leader in the alternative health care industry, is strongly opposed to this legislation being passed, and encourages consumers to take action.

19 Feb 2010

Nuvo Research reports net income in fourth-quarter, driven by FDA approval of Pennsaid

Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the year and the fourth quarter ended December 31, 2009.

19 Feb 2010

EQ Labs enters into partnership with one of the world's largest private label tablet manufacturers

EQ Labs, Inc., a manufacturer and distributor of the EQ Smart Energy Drink® effervescent tablets, announced today that it has entered into a partnership with one of the world's largest private label tablet manufacturers who has the capacity to produce one million EQ drink tablets per day.

19 Feb 2010

Five best practices for medical device industry

In early 2010, regulations in the medical device industry are already coming under increased scrutiny as product recalls and new research raise concerns about consumer safety. Regulatory authorities are responding on multiple levels, from the FDA's public meeting on pre-market medical device notification to new investments in medical product safety.

19 Feb 2010

Depomed receives final meeting minutes from FDA for pre-NDA meeting on DM-1796 for PHN

Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.

19 Feb 2010

Parker Waichman Alonso applauds GSK for deciding to stop manufacturing denture adhesive products made with zinc

The attorneys of Parker Waichman Alonso LLP applaud GlaxoSmithKline for its decision to voluntarily stop the manufacture, distribution and advertising of all Super PoliGrip denture adhesive products made with zinc.

19 Feb 2010

DSM Pharmaceutical Products wins Profiles in Sustainability award

DSM Pharmaceutical Products, based in Parsippany, NJ, today announced that it has received a Profiles in Sustainability award from United Business Media and ICIS Chemical Business. United Business Media Limited is a leading global business media company and parent of InformexUSA, where the award was announced today in San Francisco.

19 Feb 2010

Echo Therapeutics makes significant advance in designing Symphony tCGM device

Echo Therapeutics, Inc., a company developing the needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, announced today that the Company has made a significant advance in the product design of its Symphony tCGM device and that it has developed its next generation electronic component package.

19 Feb 2010

Epeius Biotechnologies completes construction of VPU to manufacture targeted genetic medicines

Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.

18 Feb 2010

OPKO Health acquires Pharmacos Exakta

OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. (“Pharmacos Exakta”), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.

18 Feb 2010

Incyte announces 2009 financial results and key fourth-quarter accomplishments

Incyte Corporation today reported fourth quarter and full year 2009 financial results, provided an update on key fourth quarter accomplishments and 2010 objectives, and announced its 2010 financial guidance.

18 Feb 2010

Taro Pharmaceutical Industries to discontinue manufacturing operations in Roscrea, Ireland

Taro Pharmaceutical Industries Ltd. today announced that it will discontinue manufacturing operations at the sterile manufacturing facility of its Irish subsidiary, Taro Pharmaceuticals Ireland Limited, in Roscrea, Ireland (“Taro Ireland”).

18 Feb 2010

West Pharmaceutical Services reports 19.9% growth in consolidated fourth-quarter sales

West Pharmaceutical Services, Inc. today announced its results for the fourth quarter and full year of 2009.

18 Feb 2010

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

On the first anniversary of the American Recovery and Reinvestment Act (ARRA) - the economic stimulus - the nation's research universities today provided nearly 100 examples of how a relatively small element of the measure is paying outsize short- and long-term dividends for the nation. Of the $787 billion contained in the ARRA, $21.5 billion is allocated for research and science infrastructure.

18 Feb 2010

AutoGenomics awarded ISO 13485 certification for quality management system

AutoGenomics, a leader in providing automated, molecular testing solutions announced today that the organization has been awarded the ISO 13485 certification in recognition of its outstanding quality management system throughout the organization. TUV SUD America Inc. was the Certification Body.

18 Feb 2010

AMRI announces Excelsyn acquisition

AMRI today announced the acquisition of Excelsyn Ltd., a well recognized leader in providing chemical development and manufacturing services to the pharmaceutical industry in Europe. Located in Holywell, North Wales, UK, Excelsyn has 60 employees and generated revenue of $15 million in 2009.

18 Feb 2010

Rondaxe and TD2 announce cancer drug development alliance

TGen Drug Development (TD2) and Rondaxe Enterprises today announced a strategic alliance that will help emerging companies speed new high-quality treatments to cancer patients.

18 Feb 2010

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

18 Feb 2010

Biogen Idec, Swedish Orphan Biovitrum restructure collaboration agreement for rFVIIIFc and rFIXFc programs

Biogen Idec and Swedish Orphan Biovitrum today announced that they have restructured the collaboration agreement for the companies’ long-acting, recombinant Factor VIII Fc fusion protein (rFVIIIFc) in hemophilia A patients and the recombinant Factor IX Fc fusion protein (rFIXFc) in hemophilia B patients.

18 Feb 2010

Manufacturing News and Research

Further Reading

L-3 Communications enters into agreement to acquire Insight Technology

Passage of DSSA will restrict Americans’ access to nutritional supplements, says Hotze Enterprises

Nuvo Research reports net income in fourth-quarter, driven by FDA approval of Pennsaid

EQ Labs enters into partnership with one of the world's largest private label tablet manufacturers

Five best practices for medical device industry

Depomed receives final meeting minutes from FDA for pre-NDA meeting on DM-1796 for PHN

Parker Waichman Alonso applauds GSK for deciding to stop manufacturing denture adhesive products made with zinc

DSM Pharmaceutical Products wins Profiles in Sustainability award

Echo Therapeutics makes significant advance in designing Symphony tCGM device

Epeius Biotechnologies completes construction of VPU to manufacture targeted genetic medicines

OPKO Health acquires Pharmacos Exakta

Incyte announces 2009 financial results and key fourth-quarter accomplishments

Taro Pharmaceutical Industries to discontinue manufacturing operations in Roscrea, Ireland

West Pharmaceutical Services reports 19.9% growth in consolidated fourth-quarter sales

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

AutoGenomics awarded ISO 13485 certification for quality management system

AMRI announces Excelsyn acquisition

Rondaxe and TD2 announce cancer drug development alliance

Sorin Group's newest generation C5 HLM system receives FDA clearance

Biogen Idec, Swedish Orphan Biovitrum restructure collaboration agreement for rFVIIIFc and rFIXFc programs

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®